Seneffe, August 26, 2016. Eckert & Ziegler BEBIG SA took over 100 % of the shares in BrachySolutions BVBA effective August 26, 2016. The company, which is based in Leuven, Belgium, is one of the largest independent European distributors of prostate seeds. Its main markets are Benelux and Portugal. Both parties have agreed not to disclose the purchase price.
Through the takeover, Eckert & Ziegler is acquiring
BrachySolutions' customer base in Benelux, the United Kingdom, and Portugal,
thereby securing its strong position in Europe as a manufacturer of seeds.
"By acquiring BrachySolutions, we are further honing our
strategic focus. Our strategy centers on consolidating the market, cementing
our market position in Europe, and creating synergies within our portfolio of
solutions," said Dr. Harald Hasselmann, Managing Director of Eckert &
Ziegler BEBIG and member of the Board of Directors.
"Eckert & Ziegler's Berlin-made prostate implants stand
for top quality. I believe firmly that our brachytherapy customers will
continue to receive the best possible products and excellent service in the
future," Luk Herremans, founder and Managing Director of BrachySolutions,
added.
Brachytherapy is a medical treatment method that includes placing
implants containing radioisotopes directly into tumor tissue. The local
radiation provided by the implants leads to the destruction of cancer cells.
Permanent brachytherapy is mainly used to treat prostate cancer.
Source: Eckert & Ziegler BEBIG via GlobeNewswire